Skip to main content
Tech.euFundingExplorerBeta

Integra Therapeutics

Next-generation gene-editing tools to boost the efficiency and safety of advanced therapies.

Total raised
€27M
€27,200,000
Funding rounds
4
Investors
9
distinct backers
Active since
2021-12
latest 2025-09

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood48
base rate 44% for Seed
  • In typical raise window
  • Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
  • 4 rounds raised

Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.